Snowball logo
logo

Natco Pharma Limited

797.90-4.60  (0.57%)
Start your journey to financial independence
Snowball will help you to track your portfolio, plan deposits to your brokerage account and increase passive income
Start

Frequently Asked Questions

What sector does Natco Pharma Limited (NATCOPHARM) operate in?

Natco Pharma Limited belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.

What is Natco Pharma Limited (NATCOPHARM) current stock price?

As of the latest data, Natco Pharma Limited stock price is ₹797.90, with a previous close of ₹802.50. Natco Pharma Limited lost -₹4.60 in the last trading session, representing a -0.57% loss.

What is Natco Pharma Limited (NATCOPHARM) current market capitalization?

Natco Pharma Limited market cap is approximately 142.91 billion.

What is Natco Pharma Limited (NATCOPHARM) Earnings Per Share (EPS)?

The trailing EPS is ₹104.15, and the forward EPS is ₹104.55.

What is Natco Pharma Limited (NATCOPHARM) Price-to-Earnings (P/E) ratio?

Natco Pharma Limited current P/E ratio is 7.66, with a forward P/E of 7.63.

What is Natco Pharma Limited (NATCOPHARM) EBITDA?

Natco Pharma Limited EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 2.15 billion.

Does Natco Pharma Limited (NATCOPHARM) dividends?

Yes. Natco Pharma Limited pays other dividends with a forward yield of 0.56% and a forward payout of ₹4.50 per share.

When is the next ex-dividend date for Natco Pharma Limited (NATCOPHARM)?

The next ex-dividend date is scheduled for June 18, 2025.

How did Natco Pharma Limited (NATCOPHARM) perform in its most recent earnings report?

In the last report (December 31, 2024), Natco Pharma Limited posted an EPS surprise of -44.39% and a revenue surprise of -44.52%.

When is Natco Pharma Limited (NATCOPHARM) next earnings report?

Natco Pharma Limited is expected to release its next earnings report on June 30, 2025.

What is Natco Pharma Limited (NATCOPHARM) beta (volatility) score?

Natco Pharma Limited has a beta of 0.519, indicating lower volatility than the overall market.